Blueprint Medicines

Genomically defined diseases, Hepatocellular carcinoma, Kinase inhibitor, Novel cancer therapies, Oncology drug discovery, Orphan drugs, Personalized medicine, Precision therapy, Robust drug pipeline, Small molecules, Transformative drugs, allergy/inflammatory, blood disorders, breast cancer, cancer immunotherapy, drug design, genomically defined cancers, hematology, hematology/oncology, lung cancer, mast cell biology, molecular targeting, non-small cell lung cancer, oncology, rare diseases, solid tumors, systemic mastocytosis, targeted therapy